96 Additionally, AMPK activation by reduced ATP levels maintains NADPH through inhibiting NADPH consumption in fatty-acid synthesis and enhancing NADPH production from fatty-acid oxidation instead of PPP to inhibit cell death
Sheen, 1998
Here is what GLP-1 clients commonly experience that the prescription insert glosses over: Ozempic face & body : rapid fat loss without skin support leads to sagging, hollowness, and a drawn, aged appearance Muscle wasting : the body breaks down lean tissue when protein intake drops and no targeted support is in place Digestive disruption : GLP-1 medications slow gastric emptying, causing bloating, constipation, and general GI discomfort Fatigue : eating less means less fuel, and without metabolic support, energy levels drop significantly Emotional flatness : rapid body changes, hormonal shifts, and reduced food reward create a kind of low-grade emotional numbness many clients do not expect Plateaus : the body adapts, metabolism slows, and weight loss stalls even when the medication is working None of this means GLP-1 medications are wrong for you
COVID-19, ACE2, and the cardiovascular consequences
Significant weight loss can also lead to changes in facial bone density and soft tissue volume, which some patients notice as a sunken look
